- API
Any substance that is represented for use in a drug and that, when used in the manufacturing, processing, or packaging ...
- Active Ingredient
Any component that is intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, ...
- CAS No.
Unique number assigned to a specific chemical (identified by its chemical name) by the American Chemical Society and ...
Artemisinin
Catalog No. | PI0016 |
---|---|
CAS No. | 63968-64-9 |
Molecular Formula | C15H22O5 |
Molecular Weight | 282.33 |
Purity | 99% HPLC |
Package | 25 kg/drum |
Botanical Source | Artemisia Annua |
Appearance | White powder |
Storage | Stored in cool and dry places, protected from direct sunlight and heat. |
Shelf Life | 2 years |
Safety Tips of Artemisinin
Handling of artemisinin should only be performed by personnel trained and familiar with handling of potent active pharmaceutical ingredients. Moderate to severe irritant to the skin and eyes.
Related Products
-
Catalog No.: PI0047
CAS No.: 27200-12-0
Molecular Weight: 320.25
Purity: 98% HPLC
Package: 25 kg/drum
-
Catalog No.: HE0021
Specification: 20% 50% UV Polysaccharide; 0.4%, 5%, 10%-90% Astragaloside IV HPLC
Package: 25 kg/drum
Botanical Source: Astragalus Membranaceus Bge
Related Applications
Antibacterial and Anti-inflammatory
Antibiotics are medicines that kill microorganisms and cure bacterial infections. Conventional medicine has produced a number of antibiotics, which doctors prescribe for a variety of infectious conditions. There are also several herbs used as natural antibiotics that are considered antibacterial or antimicrobial. Some medicines not only have an anesthetization function but also have the ability to decrease swelling, alleviate pain, resist bacteria, diminish inflammation, disinfect and sterilize. Herbal extract possesses these activities with lower toxicities.
Related Researches
- 1. Genetic Surveillance Detects Both Clonal and Epidemic Transmission of Malaria following Enhanced Intervention in Senegal.
Daniels R, et al. PLoS One 2013 Apr 4;8(4):e60780.
- 2. Quantitative Structure-Activity Relationships of the Antimalarial Agent Artemisinin and some of its Derivatives - A DFT Approach.
Rajkhowa S, et al. Comb Chem High Throughput Screen 2013 Apr 10.
- 3. Expression in yeast links field polymorphisms in PfATP6 to in vitro artemisinin resistance and identifies new inhibitor classes.
Pulcini S, et al. J Infect Dis 2013 Apr 18.
- 4. Early parasitological response following artemisinin-containing regimens: a critical review of the literature.
Das D, et al. Malar J 2013 Apr 19;12(1):125.
- 5. A new derivative detected in accelerated ageing of artesunate-amodiaquine fixed dose combination tablets.
Charrier C, et al. J Pharm Biomed Anal 2013 Mar 26;81-82C:20-26.
- 6. Artemisinin-based combination therapy availability and use in the private sector of five AMFm phase 1 countries.
Davis B, et al. Malar J 2013 Apr 22;12:135.
- 7. Toxic essential oils. Part II: Chemical, toxicological, pharmacological and microbiological profiles of Artemisia annua L. volatiles.
Radulovi? NS, et al. Food Chem Toxicol 2013 Apr 20.
- 8. The Artemisinin derivative Artesunate inhibits corneal neovascularization by inducing ROS-dependent apoptosis in vascular endothelial cells.
Cheng R, et al. Invest Ophthalmol Vis Sci 2013 Apr 23.
- 9. High-throughput analysis of antimalarial susceptibility data by the WWARN In Vitro Analysis and Reporting Tool (IVART).
Woodrow CJ, et al. Antimicrob Agents Chemother 2013 Apr 22.
- 10. Ex vivo responses of Plasmodium falciparum clinical isolates to conventional and new antimalarial drugs in Niger.
Issaka M, et al. Antimicrob Agents Chemother 2013 Apr 22.